Wuxi Biologics

Wuxi Biologics's reported carbon emissions

## Wuxi Biologics: Emissions Overview and Climate Commitments Wuxi Biologics, headquartered in China and operating within the Research and Development in Biotechnology (except Nanobiotechnology) sector, has reported significant progress in its climate action. **Emissions Data:** For the fiscal year 2025, Wuxi Biologics reported a total of approximately **230 million kg CO2e** in Scope 1 and 2 emissions. Breaking this down further: * **Scope 1 emissions:** Approximately **44.1 million kg CO2e**. * **Scope 2 emissions:** Approximately **185.6 million kg CO2e**. In 2024, the company's Scope 1 and 2 emissions totalled approximately **198.7 million kg CO2e**, with Scope 1 emissions at about **38.3 million kg CO2e** and Scope 2 emissions at approximately **160.3 million kg CO2e**. Prior to this, in 2023, Wuxi Biologics' Scope 1 and 2 emissions were approximately **181.9 million kg CO2e**, comprising around **32.7 million kg CO2e** from Scope 1 and roughly **149.2 million kg CO2e** from Scope 2. For 2022, the company's Scope 1 and 2 emissions amounted to approximately **169.8 million kg CO2e**, with Scope 1 at about **33.8 million kg CO2e** and Scope 2 at approximately **136.1 million kg CO2e**. In 2021, Wuxi Biologics reported Scope 1 and 2 emissions of approximately **144.2 million kg CO2e**, consisting of roughly **29.9 million kg CO2e** in Scope 1 and about **114.3 million kg CO2e** in Scope 2. In 2020, the company's Scope 1 and 2 emissions were approximately **85.4 million kg CO2e**, with Scope 1 at around **11.0 million kg CO2e** and Scope 2 at approximately **74.4 million kg CO2e**. For 2019, Wuxi Biologics reported Scope 1 and 2 emissions totalling approximately **78.9 million kg CO2e**, with Scope 1 at about **10.6 million kg CO2e** and Scope 2 at approximately **68.3 million kg CO2e**. In 2018, the company's Scope 1 and 2 emissions were approximately **54.3 million kg CO2e**, comprising around **4.2 million kg CO2e** from Scope 1 and approximately **50.1 million kg CO2e** from Scope 2. While Scope 3 data is increasingly being disclosed, specific total figures for Scope 3 emissions across all categories are not fully detailed for all reported years. For 2025, some Scope 3 categories reported include business travel (approximately 3.9 million kg CO2e), employee commute (approximately 22.5 million kg CO2e), and waste generated in operations (approximately 5.9 million kg CO2e). **Climate Commitments and Reduction Targets:** Wuxi Biologics has set ambitious climate targets aligned with a 1.5°C pathway. Key commitments include: * **Net-Zero Goal:** The company commits to achieving net-zero greenhouse gas emissions across its value chain by 2050. * **Near-Term Absolute Reductions:** Wuxi Biologics aims to reduce absolute Scope 1 and 2 greenhouse gas (GHG) emissions by 58.8% by 2034, using 2024 as the base year. * **Long-Term Absolute Reductions:** The company targets a 90% reduction in absolute Scope 1 and 2 GHG emissions by 2050, also from a 2024 baseline. * **Scope 3 Reduction:** Wuxi Biologics is committed to reducing Scope 3 GHG emissions, specifically for purchased goods and services, by 63.8% per kg of product produced by 2034. Furthermore, there is a commitment to reduce absolute Scope 3 emissions (covering purchased goods and services, capital goods, fuel and energy-related activities, upstream transportation and distribution, waste generated in operations, and employee commuting) by 90% by 2050. * **Intensity Reduction (Mid-term):** Previously, the company had a mid-term goal to reduce its Scope 1 and 2 GHG emission intensity by 50% (tonnes/RMB10,000) by 2030, based on a 2020 baseline. These commitments are publicly available through their Science Based Targets initiative (SBTi) disclosures, demonstrating a clear strategy to decarbonise their operations and value chain.